The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 11, 2019

Filed:

Nov. 30, 2018
Applicant:

Pfizer Inc., New York, NY (US);

Inventors:

Katherine Lin Lee, West Newton, MA (US);

Christophe Philippe Allais, Ledyard, CT (US);

Christoph Martin Dehnhardt, Burnaby, CA;

Lori Krim Gavrin, Villanova, PA (US);

Seungil Han, Mystic, CT (US);

David Hepworth, Concord, MA (US);

Arthur Lee, San Carlos, CA (US);

Frank Eldridge Lovering, Acton, MA (US);

John Paul Mathias, Concord, MA (US);

Dafydd Rhys Owen, Concord, MA (US);

Nikolaos Papaioannou, Newton, MA (US);

Eddine Saiah, Brookline, MA (US);

Joseph Walter Strohbach, Wentzville, MO (US);

John David Trzupek, Arlington, MA (US);

Stephen Wayne Wright, Old Lyme, CT (US);

Christoph Wolfgang Zapf, Marlborough, MA (US);

Assignee:

Pfizer Inc., New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4375 (2006.01); A61K 31/4709 (2006.01); A61K 31/4725 (2006.01); A61K 31/4745 (2006.01); A61K 31/4015 (2006.01); A61K 45/06 (2006.01); C07D 401/12 (2006.01); C07D 413/04 (2006.01); C07D 207/273 (2006.01); C07D 491/18 (2006.01); C07D 471/04 (2006.01); C07D 413/14 (2006.01); C07D 401/14 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); A61K 31/4015 (2013.01); A61K 31/4375 (2013.01); A61K 31/4709 (2013.01); A61K 31/4725 (2013.01); A61K 31/4745 (2013.01); A61K 45/06 (2013.01); C07D 207/273 (2013.01); C07D 401/14 (2013.01); C07D 413/04 (2013.01); C07D 413/14 (2013.01); C07D 471/04 (2013.01); C07D 491/18 (2013.01);
Abstract

Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.


Find Patent Forward Citations

Loading…